FibroBiologics Says Australian Patent Accepted for Cellular Blend
FibroBiologics said an Australian patent was accepted for a cellular blend intended to regenerate chondrocytes and cartilage cells in degenerated spinal discs.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
FibroBiologics said an Australian patent was accepted for a cellular blend intended to regenerate chondrocytes and cartilage cells in degenerated spinal discs.
The accepted patent covers a cellular blend for regenerating chondrocytes and cartilage cells in degenerated spinal discs.